medigraphic.com
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

2019, Number 2

<< Back Next >>

Rev Invest Clin 2019; 71 (2)

Frequency of Depression and Anxiety Symptoms in Mexican Patients with Rheumatic Diseases Determined by Self-Administered Questionnaires Adapted to the Spanish Language

Pérez-García LF, Silveira LH, Moreno-Ramírez M, Loaiza-Félix J, Rivera V, Amezcua-Guerra LM

Language: English
References: 20
Page: 91-97
PDF size: 140.11 Kb.


ABSTRACT

Background: The frequency of depression and anxiety symptoms in Spanish-speaking patients suffering from rheumatic conditions is unknown when using self-administered detection tools. Methods: A single-center, cross-sectional survey including 413 patients (341 women) with well-defined rheumatic diseases was conducted. The patient health questionnaire-9 (PHQ-9) and generalized anxiety disorder (GAD)-7 questionnaires were used to detect depression and anxiety symptoms, respectively. Results: A total of 193 patients (46.7%) reported depression symptoms, and increased PHQ-9 scores were more frequently observed in women than in men (23% vs. 13%; p = 0.038), particularly in association with osteoarthritis, fibromyalgia, Sjögren’s syndrome, and osteoporosis. From 88 patients (21.3%) with PHQ-9 scores ≥ 10 points (moderate-to-severe depression symptoms), 27 (30.6%) were previously diagnosed to have depression and only four were under antidepressant treatment. Anxiety symptoms were observed in 168 patients (40.6%) and classified as moderate-to-severe by elevated GAD-7 scores in 68 subjects (16.4%). Of them, 12 (17.6%) were previously diagnosed with GAD, but only 4 (5.8%) were under therapy. Conclusions: An unexpected and unusually high frequency of undiagnosed depression and anxiety symptoms was found in rheumatic patients. Self-administered screening tools adapted to the Spanish language are useful and may help clinicians to suspect these conditions.


REFERENCES

  1. Anyfanti P, Gavriilaki E, Pyrpasopoulou A, et al. Depression, anxiety, and quality of life in a large cohort of patients with rheumatic diseases: common, yet undertreated. Clin Rheumatol. 2016;35:733-9.

  2. Mitchell AJ, Vaze A, Rao S. Clinical diagnosis of depression in primary care: a meta-analysis. Lancet. 2009;374:609-19.

  3. Interian A, Ang A, Gara MA, Rodriguez MA, Vega WA. The longterm trajectory of depression among latinos in primary care and its relationship to depression care disparities. Gen Hosp Psychiatry. 2011;33:94-101.

  4. Senra H, Rogers H, Leibach G, et al. Health-related quality of life and depression in a sample of latin american adults with rheumatoid arthritis. Int J Rheum Dis. 2017;20:1684-93.

  5. Matcham F, Norton S, Scott DL, Steer S, Hotopf M. Symptoms of depression and anxiety predict treatment response and longterm physical health outcomes in rheumatoid arthritis: secondary analysis of a randomized controlled trial. Rheumatology (Oxford). 2016;55:268-78.

  6. Baillet A, Gossec L, Carmona L, et al. Points to consider for reporting, screening for and preventing selected comorbidities in chronic inflammatory rheumatic diseases in daily practice: a EULAR initiative. Ann Rheum Dis. 2016;75:965-73.

  7. Gómez-Valero S, García-Pérez F, Flórez-García MT, Miangolarra- Page JC. Revisión sistemática de los cuestionarios autocumplimentados adaptados al español para la valoración funcional de pacientes con afecciones de rodilla. Rev Esp Cir Ortop Traumatol. 2017;61:96-103.

  8. Epstein J, Santo RM, Guillemin F. A review of guidelines for crosscultural adaptation of questionnaires could not bring out a consensus. J Clin Epidemiol. 2015;68:435-41.

  9. Diez-Quevedo C, Rangil T, Sanchez-Planell L, Kroenke K, Spitzer RL. Validation and utility of the patient health questionnaire in diagnosing mental disorders in 1003 general hospital spanish inpatients. Psychosom Med. 2001;63:679-86.

  10. Matcham F, Ali S, Irving K, Hotopf M, Chalder T. Are depression and anxiety associated with disease activity in rheumatoid arthritis? A prospective study. BMC Musculoskelet Disord. 2016; 17:155.

  11. García-Campayo J, Zamorano E, Ruiz MA, et al. Cultural adaptation into spanish of the generalized anxiety disorder-7 (GAD-7) scale as a screening tool. Health Qual Life Outcomes. 2010;8:8.

  12. Matcham F, Rayner L, Steer S, Hotopf M. The prevalence of depression in rheumatoid arthritis: a systematic review and meta-analysis. Rheumatology (Oxford). 2013;52:2136-48.

  13. Zhong Q, Gelaye B, Fann JR, Sanchez SE, Williams MA. Crosscultural validity of the spanish version of PHQ-9 among pregnant peruvian women: a rasch item response theory analysis. J Affect Disord. 2014;158:148-53.

  14. Zhong QY, Gelaye B, Zaslavsky AM, et al. Diagnostic validity of the generalized anxiety disorder-7 (GAD-7) among pregnant women. PLoS One. 2015;10:e0125096.

  15. World Health Organisation. Depression Factsheet. WHO 2017. p. 1. Available from: http://www.who.int/mediacentre/factsheets/ fs369/en/. [Last accessed on 2018 Oct 24].

  16. González HM, Tarraf W, Whitfield KE, Vega WA. The epidemiology of major depression and ethnicity in the united states. J Psychiatr Res. 2010;44:1043-51.

  17. Suárez-Mendoza AA, Cardiel MH, Caballero-Uribe CV, Ortega- Soto HA, Márquez-Marín M. Measurement of depression in Mexican patients with rheumatoid arthritis: validity of the beck depression inventory. Arthritis Care Res. 1997;10:194-9.

  18. Soria-Saucedo R, Lopez-Ridaura R, Lajous M, Wirtz VJ. The prevalence and correlates of severe depression in a cohort of Mexican teachers. J Affect Disord. 2018;234:109-16.

  19. Familiar I, Ortiz-Panozo E, Hall B, et al. Factor structure of the spanish version of the patient health questionnaire-9 in Mexican women. Int J Methods Psychiatr Res. 2015;24:74-82.

  20. Rafful C, Medina-Mora ME, Borges G, Benjet C, Orozco R. Depression, gender, and the treatment gap in Mexico. J Affect Disord. 2012;138:165-9.




2020     |     www.medigraphic.com